177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy
Cancer. 2010 Feb 15;116(4 Suppl):1084-92.
Garkavij M, Nickel M, Sjögreen-Gleisner K, Ljungberg M, Ohlsson T, Wingårdh K, Strand SE, Tennvall J.
(177) Lu-(DOTA0, Tyr3) octreotide è una nuova modalità di trattamento per i tumori neuroendocrini diffusi.
Octreotide (DOTA)/tumori neuroendocrini diffusi.